Paul Krzyzanowski, Phd, Mba Email & Phone Number

Toronto, ON, CA

Toronto, CA

Toronto, Ontario, CA

- Lead a team of 12 to develop and manage a portfolio of clinical and RUO genomics services, including clinically reported deep whole genome/transcriptomes, custom capture assays, and liquid biopsy assays for a wide variety of cancers- Manage cross-functional project teams within a matrixed environment, including licensed Medical Laboratory Technologists.

Toronto, Ontario, CA

Toronto, Ontario, CA

- Responsible for building out one of Canada’s largest CAP/ISO15189 compliant genomics research laboratories to support large scale genome sequencing initiatives at a National Level- Responsible for incorporation of academic and commercial technologies (wet and dry lab) to leverage platform resources into new cancer research applications, as market demand.

Toronto, Ontario, CA

- Position renamed to Institute Scientist in August 2020 due to Principal Investigator complaints about the word Principal

Toronto, Ontario, CA

- Developed and implemented strategies around new product and services development in the genomics research market- Conducted business development activities, growing revenues by 22% per year over two years (2017-2019) to $4M annually- Prepared business cases for large capital investments ($300k-$1M+), successfully attracting $1.4M in funding for.

Toronto, Ontario, CA

· Led a team scientific staff to provide genetic sequencing service to internal/external researchers while managing a multimillion annual budget· Developed internal strategies around pricing, cost recovery systems, and operations to capture value currently delivered by this department· Provided business process improvement recommendations to senior.

Toronto, Ontario, CA

- Led an international (Canada-US) multi-center research study to understand how esophageal cancer develops from a precursor lesion of the esophagus, called Barrett’s Esophagous- Developed new analysis methods to integrate genomic sequences from approximately 1700 samples obtained from patients with esophageal adenocarcinoma or Barrett’s Esophagous with.

Toronto, Ontario, CA

Contributed articles and opinions regarding the use of stem cells and regenerative medicine technology in the biotechnology industry for www.signalsblog.ca. Some highlighted articles include:- The academic background of Aldagen's intellectual propertyhttp://www.signalsblog.ca/the-payoff-of-patenting-your-research-aldagen-as-a-case-study/- A review and.

CA

• I drove a research project to analyze 42 patient-derived ovarian cancer cell lines using RNA-seq, exome sequencing, and functional shRNA screening, with the objective of identifying specific vulnerabilities targetable.
• Design and implementation of the overall project,
• Management of biological research related Big Data, encompassing a >23TB dataset,
• Project management throughout stages of data generation and analysis,
• Engaging and building relationships amongst project stakeholders, including Principal Investigators, collaborators, technicians, and students,
• Communication of project progress using oral presentations, written reports, funding proposals, publications, and conference abstracts.

CA

• I worked with Drs. Miguel Andrade-Navarro and Michael Rudnicki to develop genome analysis algorithms, achieving the following goals:
• Identified many novel noncoding RNAs expressed during muscle regeneration.
• Published a novel computational method to predict protein markers associated with stem cells.

Master Of Business Administration (M.B.A.)

Phd, Molecular Medicine

Hbsc, Molecular Genetics

Hbsc, Molecular Genetics & Biology